Hinman syndrome Advocacy Hub | UniteRare

At a Glance

Live from database

💊

Regulatory Watchboard

10 events

Sep 2026The Effect of Nitrogen Narcosis on Motor Performance in Divers Who Have Sustained an Inner Ear Decompression Illness

University of Plymouth

TrialNOT YET RECRUITING

Apr 2026Remibrutinib Open Label Roll-over Post-trial Access Protocol

Novartis Pharmaceuticals — PHASE3

TrialNOT YET RECRUITING

Mar 2026Testing the Safety of the Anti-cancer Drug, Sn-117m-DTPA, for Advanced Cancers That Have Spread to Bones

National Cancer Institute (NCI) — PHASE1

TrialNOT YET RECRUITING

Feb 2026Safety, Tolerability and Preliminary Efficacy of NEUK203-13 in Refractory Neuroendocrine Tumor Patients

Cancer Institute and Hospital, Chinese Academy of Medical Sciences — PHASE1

TrialNOT YET RECRUITING

Feb 2026Efficacy and Safety of Tirzepatide Once Weekly Versus Placebo in Participants Who Are Either Obese or Overweight With Weight-Related Comorbidities (SURMOUNT-1)

Hudson Biotech — PHASE3

TrialRECRUITING

Feb 2026Efficacy of Gabapentin Combined With Solifenacin for Non-neurogenic Overactive Bladder in Women

Mansoura University — PHASE3

TrialNOT YET RECRUITING

Dec 2025A Clinical Trial Testing the Safety of BNT327 (an Investigational Drug) and How Well it Works When Combined With Chemotherapy for People Who Have Not Been Treated Yet for Pancreatic Cancer

BioNTech SE — PHASE2

TrialRECRUITING

Oct 2025Define Final Selection Choice Criteria for a Coloplast Catheter Ensuring Highest Patient Satisfaction Via Surveys (EVA).

Coloplast NV/SA — NA

TrialRECRUITING

Aug 2025Study of TYK-00540 Combined With Enzalutamide in Patients With Metastatic Castration-resistant Prostate Cancer（mCRPC）

TYK Medicines, Inc — PHASE1, PHASE2

TrialNOT YET RECRUITING

Jul 2025A Study to Evaluate the Safety of Dostarlimab in Adult Participants in India With Recurrent or Advanced Endometrial Cancer (EC)

GlaxoSmithKline — PHASE4

TrialNOT YET RECRUITING

Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Financial Assistance

FINANCIAL LANDSCAPE SUMMARY

Total programs

No financial assistance programs currently listed for Hinman syndrome.
Check the disease page for updates →

Approved Treatments

1 FDA-approved

MEPRON

(ATOVAQUONE)standard

GlaxoSmithKline LLC

Antimalarial [EPC]

12.1 Mechanism of Action Atovaquone is a quinone antimicrobial drug [see Microbiology ( 12.4 )] .

FDA label ↗

View full treatment details on disease page →

Clinical Trial Landscape

2 active trials

1N/A

1Unknown

2Total recruiting

Search clinical trials for Hinman syndrome →

Recent News & Research

No recent news articles indexed yet for Hinman syndrome.
Search PubMed for Hinman syndrome →

Browse all Hinman syndrome news →

Specialist Network

Top 6 by expertise

Global Clinical Leader

Daiichi Sankyo

Score 3644 trials4 pubs

Helen McShane

University of Oxford

Score 3313 trials2 pubs

Mikhail Samsonov

R-Pharm

Score 2717 trials

BioNTech Responsible Person

BioNTech SE

Score 1318 trials

Leona Holmberg

Fred Hutch/University of Washington Cancer Consortium

📍 SEATTLE, WA

Score 128 trials

Charles Theuer, MD, MD

Tracon Pharmaceuticals Inc.

📍 SAN DIEGO, CA

Score 123 trials

View all Hinman syndrome specialists →

Quick Actions

📄

View Disease Page

Full profile, treatments, community

🔬

Search Clinical Trials

Find recruiting studies now

🩺

Find Specialists

Ranked by expertise & trials

💰

Financial Assistance

Copay cards, PAPs, grants

📰